Jupiter Research Capital (Asia) Ltd’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-49,553
Closed -$1.19M – 991
2026
Q2
$1.19M Sell
49,553
-49,858
-50% -$1.3M 0.13% 192
2026
Q1
$2.79M Buy
+99,411
New +$2.65M 0.31% 75

Other funds holding PFE

Jupiter Research Capital (Asia) Ltd's PFE Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd sold out of Pfizer (PFE) in Q3 2026, closing a stake of 49,553 shares — an estimated $1.19M sold.

Jupiter Research Capital (Asia) Ltd first reported a position in PFE in Q1 2026 and held it in 2 quarters. The position peaked at $2.79M in Q1 2026. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
  • Jupiter Research Capital (Asia) Ltd sold 49,553 Pfizer shares in Q3 2026, an estimated $1.19M.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Pfizer in Q1 2026 and held it in 2 quarters.
  • Jupiter Research Capital (Asia) Ltd's Pfizer position peaked at $2.79M in Q1 2026.
  • 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.